[{"study_name":"Framingham Heart Study : Dataset for Teaching Purposes","study":"biolincc_framingham","study_phs_number":"tutorial-biolincc_framingham","study_url":"not availible","form_group":[{"form_group":"No Form Groups","form":[{"form":"Full Dataset","form_description":"Full Dataset","form_name":"Full Dataset","variable_group":[{"variable_group_name":"All Variables","variable_group_description":"All variables within the study","variable":[{"variable_id":"RANDID","variable_name":"Unique identification number for each participant","variable_type":"continuous","variable_description":"Unique identification number for each participant","data_hierarchy":"biolincc_framingham/Unique identification number for each participant","derived_variable_level_data":[{}]},{"variable_id":"SEX","variable_name":"Participant sex","variable_type":"categorical","variable_description":"Participant sex","data_hierarchy":"biolincc_framingham/Participant sex","derived_variable_level_data":[{}]},{"variable_id":"PERIOD","variable_name":"Examination Cycle","variable_type":"categorical","variable_description":"Examination Cycle","data_hierarchy":"biolincc_framingham/Examination Cycle","derived_variable_level_data":[{}]},{"variable_id":"TIME","variable_name":"Number of days since baseline exam","variable_type":"continuous","variable_description":"Number of days since baseline exam","data_hierarchy":"biolincc_framingham/Number of days since baseline exam","derived_variable_level_data":[{}]},{"variable_id":"AGE","variable_name":"Age at exam (years)","variable_type":"continuous","variable_description":"Age at exam (years)","data_hierarchy":"biolincc_framingham/Age at exam (years)","derived_variable_level_data":[{"Units":"years"}]},{"variable_id":"SYSBP","variable_name":"Systolic Blood Pressure (mean of last two of three measurements) (mmHg)","variable_type":"continuous","variable_description":"Systolic Blood Pressure (mean of last two of three measurements) (mmHg)","data_hierarchy":"biolincc_framingham/Systolic Blood Pressure (mean of last two of three measurements) (mmHg)","derived_variable_level_data":[{"Units":"mmHg"}]},{"variable_id":"DIABP","variable_name":"Diastolic Blood Pressure (mean of last two of three measurements) (mmHg)","variable_type":"continuous","variable_description":"Diastolic Blood Pressure (mean of last two of three measurements) (mmHg)","data_hierarchy":"biolincc_framingham/Diastolic Blood Pressure (mean of last two of three measurements) (mmHg)","derived_variable_level_data":[{"Units":"mmHg"}]},{"variable_id":"BPMEDS","variable_name":"Use of Anti-hypertensive medication at exam","variable_type":"categorical","variable_description":"Use of Anti-hypertensive medication at exam","data_hierarchy":"biolincc_framingham/Use of Anti-hypertensive medication at exam","derived_variable_level_data":[{}]},{"variable_id":"CURSMOKE","variable_name":"Current cigarette smoking at exam","variable_type":"categorical","variable_description":"Current cigarette smoking at exam","data_hierarchy":"biolincc_framingham/Current cigarette smoking at exam","derived_variable_level_data":[{}]},{"variable_id":"CIGPDAY","variable_name":"Number of cigarettes smoked each day","variable_type":"categorical","variable_description":"Number of cigarettes smoked each day","data_hierarchy":"biolincc_framingham/Number of cigarettes smoked each day","derived_variable_level_data":[{}]},{"variable_id":"TOTCHOL","variable_name":"Serum Total Cholesterol (mg/dL)","variable_type":"continuous","variable_description":"Serum Total Cholesterol (mg/dL)","data_hierarchy":"biolincc_framingham/Serum Total Cholesterol (mg-dL)","derived_variable_level_data":[{"Units":"mg/dL"}]},{"variable_id":"HDLC","variable_name":"High Density Lipoprotein Cholesterol (mg/dL)","variable_type":"continuous","variable_description":"High Density Lipoprotein Cholesterol (mg/dL)","data_hierarchy":"biolincc_framingham/High Density Lipoprotein Cholesterol (mg-dL)","derived_variable_level_data":[{"Units":"mg/dL","Availability":"available for period 3 only"}]},{"variable_id":"LDLC","variable_name":"Low Density Lipoprotein Cholesterol (mg/dL)","variable_type":"continuous","variable_description":"Low Density Lipoprotein Cholesterol (mg/dL)","data_hierarchy":"biolincc_framingham/Low Density Lipoprotein Cholesterol (mg-dL)","derived_variable_level_data":[{"Units":"mg/dL","Availability":"available for period 3 only"}]},{"variable_id":"BMI","variable_name":"Body Mass Index, weight in kilograms/height meters squared","variable_type":"continuous","variable_description":"Body Mass Index, weight in kilograms/height meters squared","data_hierarchy":"biolincc_framingham/Body Mass Index, weight in kilograms-height meters squared","derived_variable_level_data":[{"Units":"kilograms/height meters squared"}]},{"variable_id":"GLUCOSE","variable_name":"Casual serum glucose (mg/dL)","variable_type":"continuous","variable_description":"Casual serum glucose (mg/dL)","data_hierarchy":"biolincc_framingham/Casual serum glucose (mg-dL)","derived_variable_level_data":[{"Units":"mg/dL"}]},{"variable_id":"DIABETES","variable_name":"Diabetic according to criteria of first exam treated or first exam with casual glucose of 200 mg/dL or more","variable_type":"categorical","variable_description":"Diabetic according to criteria of first exam treated or first exam with casual glucose of 200 mg/dL or more","data_hierarchy":"biolincc_framingham/Diabetic according to criteria of first exam treated or first exam with casual glucose of 200 mg-dL or more","derived_variable_level_data":[{}]},{"variable_id":"HEARTRTE","variable_name":"Heart rate (Ventricular rate) in beats/min","variable_type":"continuous","variable_description":"Heart rate (Ventricular rate) in beats/min","data_hierarchy":"biolincc_framingham/Heart rate (Ventricular rate) in beats-min","derived_variable_level_data":[{}]},{"variable_id":"PREVAP","variable_name":"Prevalent Angina Pectoris at exam","variable_type":"categorical","variable_description":"Prevalent Angina Pectoris at exam","data_hierarchy":"biolincc_framingham/Prevalent Angina Pectoris at exam","derived_variable_level_data":[{}]},{"variable_id":"PREVCHD","variable_name":"Prevalent Coronary Heart Disease defined as pre-existing Angina Pectoris, Myocardial Infarction (hospitalized, silent or unrecognized), or Coronary Insufficiency (unstable angina)","variable_type":"categorical","variable_description":"Prevalent Coronary Heart Disease defined as pre-existing Angina Pectoris, Myocardial Infarction (hospitalized, silent or unrecognized), or Coronary Insufficiency (unstable angina)","data_hierarchy":"biolincc_framingham/Prevalent Coronary Heart Disease defined as pre-existing Angina Pectoris, Myocardial Infarction (hospitalized, silent or unrecognized), or Coronary Insufficiency (unstable angina)","derived_variable_level_data":[{}]},{"variable_id":"PREVMI","variable_name":"Prevalent Myocardial Infarction","variable_type":"categorical","variable_description":"Prevalent Myocardial Infarction","data_hierarchy":"biolincc_framingham/Prevalent Myocardial Infarction","derived_variable_level_data":[{}]},{"variable_id":"PREVSTRK","variable_name":"Prevalent Stroke","variable_type":"categorical","variable_description":"Prevalent Stroke","data_hierarchy":"biolincc_framingham/Prevalent Stroke","derived_variable_level_data":[{}]},{"variable_id":"PREVHYP","variable_name":"Prevalent Hypertensive. Subject was defined as hypertensive if treated or if second exam at which mean systolic was >=140 mmHg or mean Diastolic >=90 mmHg","variable_description":"Prevalent Hypertensive. Subject was defined as hypertensive if treated or if second exam at which mean systolic was >=140 mmHg or mean Diastolic >=90 mmHg","data_hierarchy":"biolincc_framingham/Prevalent Hypertensive. Subject was defined as hypertensive if treated or if second exam at which mean systolic was >=140 mmHg or mean Diastolic >=90 mmHg","derived_variable_level_data":[{}]},{"variable_id":"ANGINA","variable_name":"Angina Pectoris","variable_type":"categorical","variable_description":"Angina Pectoris","data_hierarchy":"biolincc_framingham/Angina Pectoris","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"HOSPMI","variable_name":"Hospitalized Myocardial Infarction","variable_type":"categorical","variable_description":"Hospitalized Myocardial Infarction","data_hierarchy":"biolincc_framingham/Hospitalized Myocardial Infarction","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"MI_FCHD","variable_name":"Hospitalized Myocardial Infarction or Fatal Coronary Heart Disease","variable_type":"categorical","variable_description":"Hospitalized Myocardial Infarction or Fatal Coronary Heart Disease","data_hierarchy":"biolincc_framingham/Hospitalized Myocardial Infarction or Fatal Coronary Heart Disease","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"ANYCHD","variable_name":"Angina Pectoris, Myocardial infarction (Hospitalized and silent or unrecognized), Coronary Insufficiency (Unstable Angina), or Fatal Coronary Heart Disease","variable_type":"categorical","variable_description":"Angina Pectoris, Myocardial infarction (Hospitalized and silent or unrecognized), Coronary Insufficiency (Unstable Angina), or Fatal Coronary Heart Disease","data_hierarchy":"biolincc_framingham/Angina Pectoris, Myocardial infarction (Hospitalized and silent or unrecognized), Coronary Insufficiency (Unstable Angina), or Fatal Coronary Heart Disease","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"STROKE","variable_name":"Atherothrombotic infarction, Cerebral Embolism, Intracerebral Hemorrhage, or Subarachnoid Hemorrhage or Fatal Cerebrovascular Disease","variable_type":"categorical","variable_description":"Atherothrombotic infarction, Cerebral Embolism, Intracerebral Hemorrhage, or Subarachnoid Hemorrhage or Fatal Cerebrovascular Disease","data_hierarchy":"biolincc_framingham/Atherothrombotic infarction, Cerebral Embolism, Intracerebral Hemorrhage, or Subarachnoid Hemorrhage or Fatal Cerebrovascular Disease","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"CVD","variable_name":"Myocardial infarction (Hospitalized and silent or unrecognized), Fatal Coronary Heart Disease, Atherothrombotic infarction, Cerebral Embolism, Intracerebral Hemorrhage, or Subarachnoid Hemorrhage or Fatal Cerebrovascular Disease","variable_type":"categorical","variable_description":"Myocardial infarction (Hospitalized and silent or unrecognized), Fatal Coronary Heart Disease, Atherothrombotic infarction, Cerebral Embolism, Intracerebral Hemorrhage, or Subarachnoid Hemorrhage or Fatal Cerebrovascular Disease","data_hierarchy":"biolincc_framingham/Myocardial infarction (Hospitalized and silent or unrecognized), Fatal Coronary Heart Disease, Atherothrombotic infarction, Cerebral Embolism, Intracerebral Hemorrhage, or Subarachnoid Hemorrhage or Fatal Cerebrovascular Disease","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"HYPERTEN","variable_name":"Hypertensive. Defined as the first exam treated for high blood pressure or second exam in which either Systolic is 6 140 mmHg or Diastolic 6 90mmHg","variable_type":"categorical","variable_description":"Hypertensive. Defined as the first exam treated for high blood pressure or second exam in which either Systolic is 6 140 mmHg or Diastolic 6 90mmHg","data_hierarchy":"biolincc_framingham/Hypertensive. Defined as the first exam treated for high blood pressure or second exam in which either Systolic is 6 140 mmHg or Diastolic 6 90mmHg","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"DEATH","variable_name":"Death from any cause","variable_type":"categorical","variable_description":"Death from any cause","data_hierarchy":"biolincc_framingham/Death from any cause","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"TIMEAP","variable_name":"Number of days from Baseline exam to first Angina during the followup or Number of days from Baseline to censor date. Censor date may be end of followup, death or last known contact date if subject is lost to followup","variable_type":"categorical","variable_description":"Number of days from Baseline exam to first Angina during the followup or Number of days from Baseline to censor date. Censor date may be end of followup, death or last known contact date if subject is lost to followup","data_hierarchy":"biolincc_framingham/Number of days from Baseline exam to first Angina during the followup or Number of days from Baseline to censor date. Censor date may be end of followup, death or last known contact date if subject is lost to followup","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"TIMEMI","variable_name":"Defined as above for the first HOSPMI event during followup","variable_type":"categorical","variable_description":"Defined as above for the first HOSPMI event during followup","data_hierarchy":"biolincc_framingham/Defined as above for the first HOSPMI event during followup","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"TIMEMIFC","variable_name":"Defined as above for the first MI_FCHD event during followup","variable_type":"categorical","variable_description":"Defined as above for the first MI_FCHD event during followup","data_hierarchy":"biolincc_framingham/Defined as above for the first MI_FCHD event during followup","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"TIMECHD","variable_name":"Defined as above for the first ANYCHD event during followup","variable_type":"categorical","variable_description":"Defined as above for the first ANYCHD event during followup","data_hierarchy":"biolincc_framingham/Defined as above for the first ANYCHD event during followup","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"TIMESTRK","variable_name":"Defined as above for the first STROKE event during followup","variable_type":"categorical","variable_description":"Defined as above for the first STROKE event during followup","data_hierarchy":"biolincc_framingham/Defined as above for the first STROKE event during followup","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"TIMECVD","variable_name":"Defined as above for the first CVD event during followup","variable_type":"categorical","variable_description":"Defined as above for the first CVD event during followup","data_hierarchy":"biolincc_framingham/Defined as above for the first CVD event during followup","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"TIMEHYP","variable_name":"Defined as above for the first HYPERTEN event during followup","variable_type":"categorical","variable_description":"Defined as above for the first HYPERTEN event during followup","data_hierarchy":"biolincc_framingham/Defined as above for the first HYPERTEN event during followup","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]},{"variable_id":"TIMEDTH","variable_name":"Number of days from Baseline exam to death if occurring during followup or Number of days from Baseline to censor date. Censor date may be end of followup, or last known contact date if subject is lost to followup","variable_type":"categorical","variable_description":"Number of days from Baseline exam to death if occurring during followup or Number of days from Baseline to censor date. Censor date may be end of followup, or last known contact date if subject is lost to followup","data_hierarchy":"biolincc_framingham/Number of days from Baseline exam to death if occurring during followup or Number of days from Baseline to censor date. Censor date may be end of followup, or last known contact date if subject is lost to followup","derived_variable_level_data":[{"Availability":"Only the first event occurring during the interval of baseline (PERIOD=1) to end of followup is provided"}]}]}]}]}]}]
